Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
02/2010
02/11/2010WO2009131395A3 Angiogenic peptide
02/11/2010WO2009054873A4 Anti-rantes antibodies and methods of use thereof
02/11/2010WO2009052125A9 Human anti-amyloid antibodies, compositions, methods and uses
02/11/2010WO2009042053A9 Neuromedin u receptor agonists and uses thereof
02/11/2010WO2009003125A8 Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs
02/11/2010US20100036107 Rna interference compositions and methods
02/11/2010US20100036097 Mutant Interleukin-2 (IL-2) Polypeptides
02/11/2010US20100036084 Biodegradable poly(beta-amino esters) and uses thereof
02/11/2010US20100035974 Compositions comprising a sirna and lipidic 4,5-disubstituted 2-deoxystreptamine ring aminoglycoside derivatives and uses thereof
02/11/2010US20100035964 Antisense modulation of connective tissue growth factor expression
02/11/2010US20100035903 administering 3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile or salts, for the treatment of dermatitis, Crohn's disease, inflammatory bowel disease, transplant rejection, lupus, multiple sclerosis, arthritis, psoriasis, diabetes and autoimmune diseases
02/11/2010US20100035842 Amino alcohol compounds or phosphonic acid derivatives thereof
02/11/2010US20100035827 Multivalent metal salts of boronic acids
02/11/2010US20100035826 Controlled release of phenolic opioids
02/11/2010US20100035825 compositions and methods to suppress the activation and/or proliferation of mesenchymally derived cells, as well as cells with abnormal growth characteristics; inhibit or eliminate fibrosis; cancer
02/11/2010US20100035824 Synergistic Pharmaceutical Composition
02/11/2010US20100035823 Ligands of sh3 domains
02/11/2010US20100035822 Proline-rich peptides, pharmaceutical composition, use of one or more peptides and method of treatment
02/11/2010US20100035821 Amide Linkage Cyclic Natriuretic Peptide Constructs
02/11/2010US20100035820 Amidated dopamine neuron stimulating peptides for cns dopaminergic upregulation
02/11/2010US20100035819 Method of promoting skin collagen production
02/11/2010US20100035818 Optimized expression of hpv 52 l1 in yeast
02/11/2010US20100035817 Method for the production of conjugates of insulin-like growth factor-1 and poly(ethylene glycol)
02/11/2010US20100035816 Medicament comprising a peptide extract of avocado, which is intended for the treatment and prevention of illnesses that are linked to an immune system deficiency or oxidative stress or skin ageing or dry skin
02/11/2010US20100035815 Skin wound healing compositions and methods of use thereof
02/11/2010US20100035814 N-Terminal Pegylated Prolactin Receptor Molecules
02/11/2010US20100035813 Recombinant e-selectin made in insect cells
02/11/2010US20100035812 Modified Bovine G-CSF Polypeptides And Their Uses
02/11/2010US20100035811 Phosphoinositide Modulation For The Treatment Of Neurodegenerative Diseases
02/11/2010US20100035810 Adiponectin production enhancer
02/11/2010US20100035809 Stable liquid compositions for treating stomatitis comprising epidermal growth factor
02/11/2010US20100035808 Methods and compositions for promoting organ development
02/11/2010US20100035807 Composition and method for treatment of tumors
02/11/2010US20100035806 Compositions and Methods for Detection and Modulation of T Cell Mediated Immune Responses Against Viral Vectors Utilized for Gene Therapy
02/11/2010US20100035805 Non-aqueous liquid formulation for nasal or buccal administration
02/11/2010US20100035804 Polypeptide antagonist
02/11/2010US20100035803 Polypeptides and Polynucleotides Encoding the same
02/11/2010US20100035802 Particular short-chain peptide cancer drug and its treatment
02/11/2010US20100035801 Method for accelerating cutaneous barrier recovery
02/11/2010US20100035800 Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
02/11/2010US20100035799 Method for the synthesis of anthracycline-peptide conjugates
02/11/2010US20100035798 Methods and compositions for the topical oxygenation of hypoxic tissue
02/11/2010US20100035797 Nitric oxide-blocked cross-linked tetrameric hemoglobin
02/11/2010US20100035796 17-alpha-substituted derivatives of estradiol with wound-healing activity
02/11/2010US20100035795 Use of ultrarapid acting insulin
02/11/2010US20100035794 Use of ultrarapid acting insulin
02/11/2010US20100035793 Modulators
02/11/2010US20100035310 Production of Functional Proteins: Balance of Shear Stress and Gravity
02/11/2010US20100035271 Modification of Collagenous Materials and Medical Treatment, Diagnosis and Monitoring of Fibrotic Conditions
02/11/2010US20100034958 Infant formula
02/11/2010US20100034908 Porphyromonas gingivalis polypeptides and nucleotides
02/11/2010US20100034897 Method for Removal or Inactivation of Heparin
02/11/2010US20100034896 Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs
02/11/2010US20100034892 Treatment for bone formation disorders by growth factor delivery
02/11/2010US20100034886 Polyglutamic Acids Functionalised by Histidine Derivatives and Hydrophobic Groups and the Uses Thereof, in Particular for Therapeutic Purposes
02/11/2010US20100034884 Luminescent conducting nano-drug crystal ultra-thin film self-assembly and uses
02/11/2010US20100034880 Pharmaceutical compositions based on a microemulsion
02/11/2010US20100034867 Drug delivery coating for use with a medical device and methods of treating vascular injury
02/11/2010US20100034860 Intra-Oral Device for Treating Obesity
02/11/2010US20100034846 Novel method for treating h.pylori infections
02/11/2010US20100034842 Compositions Employing Alternative Reading Frame Polypeptides for the Treatment of Cancer and Infectious Disease
02/11/2010US20100034839 Methods for treating viral disorders
02/11/2010US20100034822 Haemophilus Influenzae Type B
02/11/2010US20100034820 Binding domain-immunoglobulin fusion proteins
02/11/2010US20100034819 Human epo mimetic hinge core mimetibodies, compositions, methods and uses for preventing or treating glucose intolerance related conditions on renal disease associated anemia
02/11/2010US20100034810 Pyrimidine derivatives for the prevention of hiv infection
02/11/2010US20100034806 Methods and Compositons for the Treatment of Marfan Syndrome and Associated Disorders
02/11/2010US20100034805 Kallikrein-inhibitor therapies
02/11/2010US20100034804 Mutants of streptokinase and their covalently modified forms
02/11/2010US20100034803 Activating agent of stem cells and/or progenitor cells
02/11/2010US20100034802 Treatment of pain
02/11/2010US20100034801 Non-Polymeric Compositions for Controlled Drug Delivery
02/11/2010US20100034800 Compositions for detecting cell death and methods of use thereof
02/11/2010US20100034799 Anti-cocaine compositions and treatment
02/11/2010US20100034797 Lipase Variants for Pharmaceutical Use
02/11/2010US20100034796 Inhibitors of fatty acid oxidation for prophylaxis and treatment of diseases related to mitochondrial dysfunction
02/11/2010US20100034788 Method for diagnosing and treating bone-related diseases
02/11/2010US20100034782 Methods of Using Anti-Thymocyte Globulin and Related Agents
02/11/2010US20100034780 Tumor antigen peptide derived from amacr
02/11/2010US20100034777 Method for Regulating Protein Function in Cells In Vivo Using Synthetic Small Molecules
02/11/2010US20100034773 5,6-dihydro-1h-pyridin-2-one compounds
02/11/2010US20100034772 Compositions and methods for immunotherapy
02/11/2010US20100034771 Combination Of Cytokine And Cytokine Receptor For Altering Immune System Functioning
02/11/2010US20100034749 Use of a Cationic Collodal Preparation for the Diagnosis and Treatment of Ocular Diseases
02/11/2010US20100034738 Structural Variants of Antibodies for Improved Therapeutic Characteristics
02/11/2010US20100034736 Identification of cancer stem cells using genetic markers
02/11/2010US20100032090 Polyurethane-Grafted Hydrogels
02/11/2010CA2735813A1 Technique for heterotropic regeneration and control of tissues and organs by using nell-1
02/11/2010CA2735710A1 Sting (stimulator of interferon genes), a regulator of innate immune responses
02/11/2010CA2733518A1 Treatment or prevention of hepatitis c with immunomodulator compounds
02/11/2010CA2733506A1 Biological applications of steroid binding domains
02/11/2010CA2733461A1 Methods of predicting cancer lethality using replikin counts
02/11/2010CA2733126A1 Methods of treating cognitive impairment
02/11/2010CA2733006A1 Analogues of glucose-dependent insulinotropic polypeptide (gip) modified at n-terminal
02/11/2010CA2733005A1 Truncated analogues of glucose-dependent insulinotropic polypeptide
02/11/2010CA2732973A1 Glucose-dependent insulinotropic polypeptide analogues
02/11/2010CA2732949A1 Analogues of glucose-dependent insulinotropic polypeptide
02/11/2010CA2732785A1 Compounds and methods
02/11/2010CA2732777A1 Pharmaceutical formulations of an hcv protease inhibitor in a solid molecular dispersion
02/11/2010CA2732449A1 Fgfr extracellular domain acidic region muteins
1 ... 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 ... 3163